Gilead faces a hepatitis C patent challenge in China by Doctors Without Borders
n the latest effort to mitigate the cost of hepatitis C drugs in a poor country, Doctors Without Borders is challenging a patent application that Gilead Sciences filed in China for its newest treatment. … Doctors Without Borders argued the patents Gilead is seeking are not warranted under Chinese law.